Back
Peyto Exploration & Development Corp. 10K Form
Buy
58
PEYUF
Peyto Exploration & Development Corp.
Last Price:
$18.48
Seasonality Move:
12.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PEYUF News And Ratings
See the #1 stock for the next 7 days that we like better than PEYUF
PEYUF Financial Statistics
Sales & Book Value
| Annual Sales: | $756M |
|---|---|
| Cash Flow: | $63.7M |
| Price / Cash Flow: | 13.51 |
| Annual Sales: | $10.23 |
| Price / Book: | 1.79 |
Profitability
| EPS (TTM): | 1.47400 |
|---|---|
| Net Income (TTM): | $299.1M |
| Gross Margin: | $282.7M |
| Return on Equity: | 15.34% |
| Return on Assets: | 7.71% |
Peyto Exploration & Development Corp. Earnings Forecast
Key Peyto Exploration & Development Corp. Financial Ratios
-
The Gross Profit Margin over the past 28 years for PEYUF is 37.39%.
-
The Selling, General & Administrative Expenses for PEYUF have been equal to 1.58% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 17.88% of Operating Income.
-
The Net Earning history of PEYUF is 39.63% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 16 years.
Peyto Exploration & Development Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | PEYUF |
| Website: | peyto.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 0.98 |
| Quick Ratio: | 0.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.44 |
|---|---|
| Forward P/E Ratio: | 11.61 |
PEYUF Technical Analysis vs Fundamental Analysis
Buy
58
Peyto Exploration & Development Corp. (PEYUF)
is a Buy
Is Peyto Exploration & Development Corp. a Buy or a Sell?
-
Peyto Exploration & Development Corp. stock is rated a BuyThe current Peyto Exploration & Development Corp. [PEYUF] share price is $18.48. The Score for PEYUF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.